FIBROBODY

Live / Registered — Registered (as of 25 Jan 2022)

What this means for you

Registered since 25 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79321550
Registration number
6624524
Mark type
Stylized text
Filed
18 Feb 2021
Published for opposition
09 Nov 2021
Registered
25 Jan 2022

Goods and services

  • Class 001 — Chemicals: Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; biochemical medicines for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents consisting of compounds that facilitate delivery of pharmaceutical preparations
  • Class 042 — Scientific and technological services: Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
  • Class 044 — Medical, beauty and agricultural services: Medical services, namely, in vitro analysis for medical and pharmaceutical use; medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the internet relating to pharmaceutical products

Owner

Prosecution history

  • 19 Sept 2025 — NEW REPRESENTATIVE AT IB RECEIVED
  • 14 Mar 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 20 Sept 2024 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 05 Jun 2022 — NOTIFICATION PROCESSED BY IB
  • 19 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
  • 18 May 2022 — FINAL DISPOSITION PROCESSED
  • 24 Feb 2022 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
  • 25 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
  • 09 Nov 2021 — PUBLISHED FOR OPPOSITION
  • 20 Oct 2021 — NOTICE OF PUBLICATION
  • 12 Oct 2021 — APPLICATION FILING RECEIPT MAILED
  • 06 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 06 Oct 2021 — ASSIGNED TO EXAMINER
  • 06 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 04 Oct 2021 — LIMITATION FROM ORIGINAL APPLICATION ENTERED

View this trademark record on Marksy